Theradaptive Secures $26M in Series A Funding to Advance Targeted Regenerative Therapeutics

Theradaptive, a Frederick, MD-based biopharmaceutical company focused on targeted regenerative therapeutics, raised $26M in Series A funding.

The round brought the total funding to over $50M. The backers were not disclosed.